compounsing semaglutide ending FDA issues warning about some compounded versions of for diabetes, weight loss Compounding pharmacies to halt semaglutide

Mass cannot be reliably verified by weighing the vial, the glass, stopper and crimp seal dwarf the peptide weight

But we need to, I need to, make sure that the oxidative stress is low enough for the body to respond to the hormones we can about to prescribe them

Obstructive sleep apnea particularly relevant given the FDA's December 2024 approval of tirzepatide specifically for obesity-related OSA also qualifies as a relevant comorbidity for patients in the BMI 27 to 29.9 range

One case report from 2024 involved an obese adolescent on low-dose liraglutide who presented with vomiting, epigastric pain, and decreased urine output and was diagnosed with an acute kidney injury (AKI) in addition to hepatic dysfunction